Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.
Ian Jacobs(Children's Hospital of Philadelphia), D Oram(Royal London Hospital for Integrated Medicine)
Cited by 366
Related Papers
Management of women who test positive for high-risk types of human papillomavirus: the HART study
|The Lancet|2003|505
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
|JNCI Journal of the National Cancer Institute|2015|441
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in <i>RAD51C</i> and <i>RAD51D</i>
|JNCI Journal of the National Cancer Institute|2020|163